Figure 2.
How PD-1 and PD-L1 inhibitors work. PD-1/PD-L1 therapies have block inhibitory signals to cytotoxic and helper T lymphocytes, B lymphocytes, natural killer cells, and macrophages and suppress the activation of regulatory T cells. RBCs, red blood cells. (Reprinted from Kroll et al1 with permission.)

How PD-1 and PD-L1 inhibitors work. PD-1/PD-L1 therapies have block inhibitory signals to cytotoxic and helper T lymphocytes, B lymphocytes, natural killer cells, and macrophages and suppress the activation of regulatory T cells. RBCs, red blood cells. (Reprinted from Kroll et al1  with permission.)

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal